483 Therapure Biopharma Aug 2019

483 Therapure Biopharma Aug 2019

Kristin Abaonza FDA$119.00 - Available Now

FDA investigators audited the Therapure Biopharma - Mississauga, Canada facility and issued inspectional observations (via FDA 483) on 28 Aug 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 28 Aug 2019
  • Location: Mississauga, Canada
  • FEI: 3007503037
Add To Cart